Gregory L. Verdine, Director at Wave Life Sciences Ltd. (WVE), sold 30,000 shares at $6.95 ($209K) on 2025-06-13, disclosed to the SEC on 2025-06-13.
Scheduled sale ($208k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| WVE | SELL | 2019-11-22 | $1.7M | — | Filing → |
| WVE | SELL | 2018-11-16 | $996K | — | Filing → |
| WVE | SELL | 2016-06-17 | $868K | — | Filing → |